212-681-1575

inspiration
In November, MesotheliomaHelp reported the U.S. Food and Drug Administration granted accelerated approval for the anti-cancer drug Tagrisso (osimertinib) for lung cancer. This approval opened the door for another mesothelioma treatment as well. Now, researchers report exciting results from a ...
Continue Reading

Want Specific topic updates?

In December, MesotheliomaHelp reported the U.S. Food and Drug Administration approved Portrazza (necitumumab) for first-line treatment of people with metastatic squamous non-small ...

Read Full Story

Want Specific topic updates?

Light_Therapy_Lamp

When being treated for mesothelioma, patients are often faced with a myriad of side effects that come along with the benefits of the cancer-fighting medicines. Fatigue, insomnia, a ...

Read Full Story

Want Specific topic updates?

Fighting cancer boxing gloves

Researchers trying to combat cancer often focus on development of a novel drug that attacks the cancer cells. But researchers from Houston Methodist Research Institute have been fo ...

Read Full Story

Want Specific topic updates?

chemotherapy words

Cancer research is a challenging field, and medical professionals and mesothelioma patients have learned that even if one study hits an obstacle, another will be close on its heels ...

Read Full Story

Want Specific topic updates?


Simple Share Buttons